antiproliferative and antioxidant effects of withania coagulans extract on benign prostatic hyperplasia in rats

conclusions w. coagulans inhibits the development of bph can be useful for the treatment of this condition. results the present study revealed that bph caused elevation of mda levels, suppression of tac levels, and increased pcna expression in the prostate gland. interestingly, in a dose-dependent manner, wce caused decreased mda levels and increased tac levels in the prostate gland, compared to the untreated bph group. histopathological examinations showed a reduction in pcna expression in the prostate epithelium of the wce animals. objectives the present study investigated the effect of withania coagulans extract (wce), which is known to have antioxidant, anti-inflammatory, antihyperglycemic, and anti-cancer properties, on testosterone-induced bph in rats. materials and methods forty wistar rats were divided into five groups (each n = 8): the control group, the untreated bph group, and three wce-treated groups (wce250, 500, and 1000). bph was induced with 3 mg/kg subcutaneous injections of testosterone propionate for four weeks. wce was concomitantly administrated by oral gavage. at the end of the induction schedule, the animals were sacrificed and their prostate glands were dissected, weighed, and fixed for histological examination (h&e; and proliferating cell nuclear antigen [pcna] staining). half of each sample was prepared for measurement of malondialdehyde (mda) and total antioxidant capacity (tac) levels in the prostate. background benign prostate hyperplasia (bph) is a common urological disorder in elderly men. phytotherapy is frequently used to alleviate the symptoms of this condition.